Zobrazeno 1 - 10
of 128
pro vyhledávání: '"G L Sannazzari"'
Autor:
Alessandro Boidi Trotti, Mario Grassini, Sola B, Andrea Riccardo Filippi, Franca Ozzello, Luca Gianello, M. Tessa, Riccardo Ragona, Daniela Nassisi, Umberto Ricardi, Mario Airoldi, Paolo Rotta, Piera Sciacero, Claudio De Angelis, G L Sannazzari
Publikováno v:
Scopus-Elsevier
Aims and Background In October 1995, the Piedmont AIRO (Italian Society of Radiation Oncology) Group started a multi-institutional study of radiochemotherapy on locally advanced esophageal cancer, characterized by external radiotherapy followed by an
Autor:
G L Sannazzari, Mario Airoldi, Sergio Gribaudo, Maria Grazia Ruo Redda, Monica Rampino, Pietro Gabriele, Roberto Orecchia, Mario Bussi, Andrea Luigi Cavalot, Riccardo Ragona
Publikováno v:
Acta oncologica (Stockholm, Sweden). 33(5)
The combination of daily low-dose carboplatin and radiotherapy was studied in 55 patients with inoperable head and neck cancer. All patients were planned to receive 70 Gy plus carboplatin i.v. daily, 45-60 min before radiotherapy. A starting schedule
Autor:
M Sacco, Giuliano Maggi, Caterina Casadio, E Manzin, Luigi Dogliotti, G L Sannazzari, Alfredo Berruti, C Loddo, Francesco Ardissone, Paola Sperone, Piero Borasio, M. Tessa, S. Bretti, Gabriella Gorzegno
Purpose: The optimal therapy for locally advanced malignant thymoma is controversial. We review our experience with a multimodal approach in 63 consecutive cases. Patients and methods: Forty-three patients had stage III and 20 stage IVa disease. Surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::239c158edc4e6e4e368ceb137864e277
http://hdl.handle.net/11379/469207
http://hdl.handle.net/11379/469207
Publikováno v:
Rays. 23(3)
Locoregional control of primary tumor is fundamental to cure since only in one third of patients the onset of distant metastases is the major cause of therapeutic failure. Thus recently, all therapeutic approaches aimed at the enhancement of locoregi
Brachytherapy for the recent technological advances, represents a fundamental "therapeutic step" in a multidisciplinary approach based on surgery, external beam radiotherapy and chemotherapy, if necessary. The various professionals involved, each wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c94d69afe5c109b5460557e72ef5c327
http://hdl.handle.net/2318/33832
http://hdl.handle.net/2318/33832
Autor:
Alessandra Faranda, Umberto Ricardi, E. Benini, Maria Grazia Daidone, Silvia Veneroni, Rosella Silvestrini, A. Urgesi, G L Sannazzari
Publikováno v:
Scopus-Elsevier
On 21 patients with T1b-T3b tumours subjected to external radiotherapy and brachytherapy, the expression of P53 and glutathione S-transferase pi [GST-pi], immunohistochemically detected, the S-phase cells fraction (H-3-thymidine labeling index, TLI)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4f43be56e07a3bafac16be7321436f1
http://hdl.handle.net/2318/27802
http://hdl.handle.net/2318/27802
Autor:
G L, Sannazzari
Publikováno v:
Rays. 21(4)
Results achieved in radiotherapy have progressively improved in the course of years for the steady technological advances which allowed to exploit at best the available equipment and to create new devices, as well as for the better radiobiological kn
The authors report their experience of high dose brachytherapy technique (HDR), relative to the first period of work, especially regarding treatment indications and preliminary clinical results. Twenty eight patients were examined, 12 of them with es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::48f3935a7e05df3a50514091b0c1ee3c
http://hdl.handle.net/2318/33871
http://hdl.handle.net/2318/33871
Publikováno v:
Scopus-Elsevier
Background In this paper the authors try to quantify the expenditure for the equipment, staff, treatment per patient and research, sustained at the Radiation Therapy Department of the University of Turin for the treatment of cancer with hyperthermia
Autor:
A, Levis, L, Depaoli, A, Urgesi, M, Bertini, L, Orsucci, U, Vitolo, G, Buchi, A, Gallamini, P, Gavarotti, A, Novarino, D, Rota Scalabrini, U, Mazza, A, Pileri, G L, Sannazzari, L, Resegotti
Publikováno v:
Haematologica. 79(1)
Elderly Hodgkin's disease patients have a poor prognosis. The question arises whether these patients need aggressive treatment or a palliative strategy. So far, as a consequence of the scarcity of trials designed for them, useful information can be o